Towards an understanding of the structure and function of MTA1

Cancer and Metastasis Reviews

Volumn 33, Issue 4, 2014, Pages 857-867

  Millard, Christopher J ^a   Fairall, Louise ^a   Schwabe, John W R ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Chromatin; Corepressor complexes; Inositol phosphate; Metastasis associated protein 1; Transcriptional regulation

Indexed keywords

CHROMATIN HELICASE DNA BINDING PROTEIN 3; CHROMATIN HELICASE DNA BINDING PROTEIN 4; COREPRESSOR PROTEIN; DNA BINDING PROTEIN; ELM2 PROTEIN; HISTONE DEACETYLASE; INOSITOL PHOSPHATE; METASTASIS ASSOCIATED PROTEIN 1; METASTASIS ASSOCIATED PROTEIN 2; METASTASIS ASSOCIATED PROTEIN 3; NUCLEOSOME REMODELLING AND DEACETYLASE; REGULATOR PROTEIN; RETINOBLASTOMA BINDING PROTEIN 4; RETINOBLASTOMA BINDING PROTEIN 7; TUMOR PROTEIN; UNCLASSIFIED DRUG; HDAC1 PROTEIN, HUMAN; HISTONE; HISTONE DEACETYLASE 1; MTA1 PROTEIN, HUMAN; REPRESSOR PROTEIN;

ARTICLE; CANCER GROWTH; CANCER THERAPY; CARBOXY TERMINAL SEQUENCE; CHROMATIN STRUCTURE; DIMERIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EPIGENETICS; GENE EXPRESSION; GENE LOCUS; HUMAN; NUCLEOSOME; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; TRANSCRIPTION REGULATION; ZINC FINGER MOTIF; CHEMISTRY; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METASTASIS; NEOPLASMS; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION;

CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE 1; HISTONE DEACETYLASES; HISTONES; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; REPRESSOR PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTIONAL ACTIVATION;

EID: 84914179395     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-014-9513-5     Document Type: Article

References (66)

1. Xue, Y., Wong, J., Moreno, G. T., Young, M. K., Côté, J., & Wang, W. (1998). NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Molecular Cell, 2(6), 851–861.
2. Zhang, Y., Ng, H.-H., Erdjument-Bromage, H., Tempst, P., Bird, A., & Reinberg, D. (1999). Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes and Development, 13(15), 1924–1935.
3. Humphrey, G. W., Wang, Y., Russanova, V. R., Hirai, T., Qin, J., Nakatani, Y., & Howard, B. H. (2001). Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. Journal of Biological Chemistry, 276(9), 6817–6824. doi:10.1074/jbc.M007372200.
4. Wen, Y. D., Perissi, V., Staszewski, L. M., Yang, W. M., Krones, A., Glass, C. K., et al. (2000). The histone deacetylase-3 complex contains nuclear receptor corepressors. Proceedings of the National Academy of Sciences of the United States of America, 97(13), 7202–7207.
5. Laherty, C. D., Yang, W. M., Sun, J. M., Davie, J. R., Seto, E., & Eisenman, R. N. (1997). Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell, 89(3), 349–356.
6. Bantscheff, M., Hopf, C., Savitski, M. M., Dittmann, A., Grandi, P., Michon, A.-M., et al. (2011). Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nature Biotechnology, 29(3), 255–265. doi:10.1038/nbt.1759.
7. Guenther, M. G., Lane, W. S., Fischle, W., Verdin, E., Lazar, M. A., & Shiekhattar, R. (2000). A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes and Development, 14(9), 1048–1057.
8. Manavathi, B., & Kumar, R. (2007). Metastasis tumor antigens, an emerging family of multifaceted master coregulators. Journal of Biological Chemistry, 282(3), 1529–1533. doi:10.1074/jbc.R600029200.
9. Denslow, S. A., & Wade, P. A. (2007). The human Mi-2/NuRD complex and gene regulation. Oncogene, 26(37), 5433–5438. doi:10.1038/sj.onc.1210611.
10. Allen, H. F., Wade, P. A., & Kutateladze, T. G. (2013). The NuRD architecture. Cellular and Molecular Life Sciences, 70(19), 3513–3524. doi:10.1007/s00018-012-1256-2.
11. Toh, Y., Pencil, S. D., & Nicolson, G. L. (1994). A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. Journal of Biological Chemistry, 269(37), 22958–22963.
12. Toh, Y., & Nicolson, G. L. (2009). The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clinical and Experimental Metastasis, 26(3), 215–227. doi:10.1007/s10585-008-9233-8.
13. Lai, A. Y., & Wade, P. A. (2011). Cancer biology and NuRD: a multifaceted chromatin remodelling complex. Nature Reviews. Cancer, 11(8), 588–596. doi:10.1038/nrc3091.
14. Zhang, H., Stephens, L. C., & Kumar, R. (2006). Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Clinical Cancer Research an Official Journal of the American Association for Cancer Research, 12(5), 1479–1486. doi:10.1158/1078-0432.CCR-05-1519.
15. Prisco, M. G., Zannoni, G. F., De Stefano, I., Vellone, V. G., Tortorella, L., Fagotti, A., et al. (2012). Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study. Human Pathology, 43(2), 282–288. doi:10.1016/j.humpath.2011.05.002.
16. Balasenthil, S., Broaddus, R. R., & Kumar, R. (2006). Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas. Human Pathology, 37(6), 656–661. doi:10.1016/j.humpath.2006.01.024.
17. Filippakopoulos, P., & Knapp, S. (2012). The bromodomain interaction module. FEBS Letters, 586(17), 2692–2704. doi:10.1016/j.febslet.2012.04.045.
18. Wade, P. A., Jones, P. L., Vermaak, D., & Wolffe, A. P. (1998). A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase. Current Biology, 8(14), 843–846.
19. Bouazoune, K., Mitterweger, A., Längst, G., Imhof, A., Akhtar, A., Becker, P. B., & Brehm, A. (2002). The dMi-2 chromodomains are DNA binding modules important for ATP-dependent nucleosome mobilization. EMBO Journal, 21(10), 2430–2440. doi:10.1093/emboj/21.10.2430.
20. Murzina, N. V., Pei, X.-Y., Zhang, W., Sparkes, M., Vicente-Garcia, J., Pratap, J. V., et al. (2008). Structural basis for the recognition of histone H4 by the histone-chaperone RbAp46. Structure, 16(7), 1077–1085. doi:10.1016/j.str.2008.05.006.
21. Brackertz, M., Gong, Z., Leers, J., & Renkawitz, R. (2006). p66alpha and p66beta of the Mi-2/NuRD complex mediate MBD2 and histone interaction. Nucleic Acids Research, 34(2), 397–406. doi:10.1093/nar/gkj437.
22. Baubec, T., Ivánek, R., Lienert, F., & Schübeler, D. (2013). Methylation-dependent and -independent genomic targeting principles of the MBD protein family. Cell, 153(2), 480–492. doi:10.1016/j.cell.2013.03.011.
23. Zhang, Y., LeRoy, G., Seelig, H. P., Lane, W. S., & Reinberg, D. (1998). The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell, 95(2), 279–289.
24. Toh, Y., Kuninaka, S., Endo, K., Oshiro, T., Ikeda, Y., Nakashima, H., et al. (2000). Molecular analysis of a candidate metastasis-associated gene, MTA1: possible interaction with histone deacetylase 1. Journal of Experimental and Clinical Cancer Research, 19(1), 105–111.
25. Alqarni, S. S. M., Murthy, A., Zhang, W., Przewloka, M. R., Silva, A. P. G., Watson, A. A., et al. (2014). Insight into the architecture of the NuRD complex: Structure of the RbAp48-MTA1 sub-complex. Journal of Biological Chemistry, 289(32), 21844–21855. doi:10.1074/jbc.M114.558940.
26. Millard, C. J., Watson, P. J., Celardo, I., Gordiyenko, Y., Cowley, S. M., Robinson, C. V., et al. (2013). Class I HDACs share a common mechanism of regulation by inositol phosphates. Molecular Cell, 51(1), 57–67. doi:10.1016/j.molcel.2013.05.020.
27. Nair, S. S., Li, D.-Q., & Kumar, R. (2013). A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes. Molecular Cell, 49(4), 704–718. doi:10.1016/j.molcel.2012.12.016.
28. Yaguchi, M., Wada, Y., Toh, Y., Iguchi, H., Kono, A., Matsusue, K., & Takiguchi, S. (2005). Identification and characterization of the variants of metastasis-associated protein 1 generated following alternative splicing. Biochimica et Biophysica Acta, 1732(1–3), 8–14. doi:10.1016/j.bbaexp.2005.12.001.
29. Kumar, R., Wang, R.-A., Mazumdar, A., Talukder, A. H., Mandal, M., Yang, Z., et al. (2002). A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm. Nature, 418(6898), 654–657. doi:10.1038/nature00889.
30. Kleene, R., Zdzieblo, J., Wege, K., & Kern, H. F. (1999). A novel zymogen granule protein (ZG29p) and the nuclear protein MTA1p are differentially expressed by alternative transcription initiation in pancreatic acinar cells of the rat. Journal of Cell Science, 112(Pt 15), 2539–2548.
31. Nawa, A., Nishimori, K., Lin, P., Maki, Y., Moue, K., Sawada, H., et al. (2000). Tumor metastasis-associated human MTA1 gene: its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides. Journal of Cellular Biochemistry, 79(2), 202–212.
32. Solari, F., Bateman, A., & Ahringer, J. (1999). The Caenorhabditis elegans genes egl-27 and egr-1 are similar to MTA1, a member of a chromatin regulatory complex, and are redundantly required for embryonic patterning. Development, 126(11), 2483–2494.
33. Nicolson, G. L., Nawa, A., Toh, Y., Taniguchi, S., Nishimori, K., & Moustafa, A. (2003). Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clinical and Experimental Metastasis, 20(1), 19–24.
34. Boyer, L. A., Latek, R. R., & Peterson, C. L. (2004). The SANT domain: a unique histone-tail-binding module? Nature Reviews Molecular Cell Biology, 5(2), 158–163. doi:10.1038/nrm1314.
35. Aasland, R., Stewart, A. F., & Gibson, T. (1996). The SANT domain: a putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB. Trends in Biochemical Sciences, 21(3), 87–88.
36. Ogata, K., Morikawa, S., Nakamura, H., Sekikawa, A., Inoue, T., Kanai, H., et al. (1994). Solution structure of a specific DNA complex of the Myb DNA-binding domain with cooperative recognition helices. Cell, 79(4), 639–648.
37. Guenther, M. G., Barak, O., & Lazar, M. A. (2001). The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Molecular and Cellular Biology, 21(18), 6091–6101.
38. Watson, P. J., Fairall, L., Santos, G. M., & Schwabe, J. W. R. (2012). Structure of HDAC3 bound to co-repressor and inositol tetraphosphate. Nature, 481(7381), 335–340. doi:10.1038/nature10728.
39. Barker, C. J., Wright, J., Hughes, P. J., Kirk, C. J., & Michell, R. H. (2004). Complex changes in cellular inositol phosphate complement accompany transit through the cell cycle. Biochemical Journal, 380(Pt 2), 465–473. doi:10.1042/BJ20031872.
40. Zhang, Y., Sun, Z. W., Iratni, R., Erdjument-Bromage, H., Tempst, P., Hampsey, M., & Reinberg, D. (1998). SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex. Molecular Cell, 1(7), 1021–1031.
41. Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002). Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes and Development, 16(22), 2893–2905. doi:10.1101/gad.1035902.
42. Barak, O., Lazzaro, M. A., Lane, W. S., Speicher, D. W., Picketts, D. J., & Shiekhattar, R. (2003). Isolation of human NURF: a regulator of Engrailed gene expression. EMBO Journal, 22(22), 6089–6100. doi:10.1093/emboj/cdg582.
43. Schmitges, F. W., Prusty, A. B., Faty, M., Stützer, A., Lingaraju, G. M., Aiwazian, J., et al. (2011). Histone methylation by PRC2 is inhibited by active chromatin marks. Molecular Cell, 42(3), 330–341. doi:10.1016/j.molcel.2011.03.025.
44. Lejon, S., Thong, S. Y., Murthy, A., AlQarni, S., Murzina, N. V., Blobel, G. A., et al. (2011). Insights into association of the NuRD complex with FOG-1 from the crystal structure of an RbAp48 FOG-1 complex. Journal of Biological Chemistry, 286(2), 1196–1203. doi:10.1074/jbc.M110.195842.
45. Roche, A. E., Bassett, B. J., Samant, S. A., Hong, W., Blobel, G. A., & Svensson, E. C. (2008). The zinc finger and C-terminal domains of MTA proteins are required for FOG-2-mediated transcriptional repression via the NuRD complex. Journal of Molecular and Cellular Cardiology, 44(2), 352–360. doi:10.1016/j.yjmcc.2007.10.023.
46. Fu, J., Qin, L., He, T., Qin, J., Hong, J., Wong, J., et al. (2011). The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis. Cell Research, 21(2), 275–289. doi:10.1038/cr.2010.118.
47. Callebaut, I., Courvalin, J. C., & Mornon, J. P. (1999). The BAH (bromo-adjacent homology) domain: a link between DNA methylation, replication and transcriptional regulation. FEBS Letters, 446(1), 189–193.
48. Nicolas, R. H., & Goodwin, G. H. (1996). Molecular cloning of polybromo, a nuclear protein containing multiple domains including five bromodomains, a truncated HMG-box, and two repeats of a novel domain. Gene, 175(1–2), 233–240.
49. Oliver, A. W., Jones, S. A., Roe, S. M., Matthews, S., Goodwin, G. H., & Pearl, L. H. (2005). Crystal structure of the proximal BAH domain of the polybromo protein. Biochemical Journal, 389(Pt 3), 657–664. doi:10.1042/BJ20050310.
50. Chambers, A. L., Pearl, L. H., Oliver, A. W., & Downs, J. A. (2013). The BAH domain of Rsc2 is a histone H3 binding domain. Nucleic Acids Research, 41(19), 9168–9182. doi:10.1093/nar/gkt662.
51. Armache, K.-J., Garlick, J. D., Canzio, D., Narlikar, G. J., & Kingston, R. E. (2011). Structural basis of silencing: Sir3 BAH domain in complex with a nucleosome at 3.0 Å resolution. Science, 334(6058), 977–982. doi:10.1126/science.1210915.
52. Wang, F., Li, G., Altaf, M., Lu, C., Currie, M. A., Johnson, A., & Moazed, D. (2013). Heterochromatin protein Sir3 induces contacts between the amino terminus of histone H4 and nucleosomal DNA. Proceedings of the National Academy of Sciences of the United States of America, 110(21), 8495–8500. doi:10.1073/pnas.1300126110.
53. Arnaudo, N., Fernández, I. S., McLaughlin, S. H., Peak-Chew, S. Y., Rhodes, D., & Martino, F. (2013). The N-terminal acetylation of Sir3 stabilizes its binding to the nucleosome core particle. Nature Structural & Molecular Biology, 20(9), 1119–1121. doi:10.1038/nsmb.2641.
54. Yang, D., Fang, Q., Wang, M., Ren, R., Wang, H., He, M., et al. (2013). Nα-acetylated Sir3 stabilizes the conformation of a nucleosome-binding loop in the BAH domain. Nature Structural and Molecular Biology, 20(9), 1116–1118. doi:10.1038/nsmb.2637.
55. Kuo, A. J., Song, J., Cheung, P., Ishibe-Murakami, S., Yamazoe, S., Chen, J. K., et al. (2012). The BAH domain of ORC1 links H4K20me2 to DNA replication licensing and Meier-Gorlin syndrome. Nature, 484(7392), 115–119. doi:10.1038/nature10956.
56. Song, J., Rechkoblit, O., Bestor, T. H., & Patel, D. J. (2011). Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation. Science, 331(6020), 1036–1040. doi:10.1126/science.1195380.
57. Zheng, R., & Blobel, G. A. (2010). GATA transcription factors and cancer. Genes & Cancer, 1(12), 1178–1188. doi:10.1177/1947601911404223.
58. Omichinski, J. G., Clore, G. M., Schaad, O., Felsenfeld, G., Trainor, C., Appella, E., et al. (1993). NMR structure of a specific DNA complex of Zn-containing DNA binding domain of GATA-1. Science, 261(5120), 438–446.
59. Ren, R., Mayer, B. J., Cicchetti, P., & Baltimore, D. (1993). Identification of a ten-amino acid proline-rich SH3 binding site. Science, 259(5098), 1157–1161.
60. Yu, H., Chen, J. K., Feng, S., Dalgarno, D. C., Brauer, A. W., & Schreiber, S. L. (1994). Structural basis for the binding of proline-rich peptides to SH3 domains. Cell, 76(5), 933–945.
61. Rigbolt, K. T. G., Prokhorova, T. A., Akimov, V., Henningsen, J., Johansen, P. T., Kratchmarova, I., et al. (2011). System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Science Signaling, 4(164), rs3. doi:10.1126/scisignal.2001570.
62. Mishra, S. K., Yang, Z., Mazumdar, A., Talukder, A. H., Larose, L., & Kumar, R. (2004). Metastatic tumor antigen 1 short form (MTA1s) associates with casein kinase I-gamma2, an estrogen-responsive kinase. Oncogene, 23(25), 4422–4429. doi:10.1038/sj.onc.1207569.
63. Toh, Y., Pencil, S. D., & Nicolson, G. L. (1995). Analysis of the complete sequence of the novel metastasis-associated candidate gene, mta1, differentially expressed in mammary adenocarcinoma and breast cancer cell lines. Gene, 159(1), 97–104.
64. Zhang, J., Kalkum, M., Chait, B. T., & Roeder, R. G. (2002). The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Molecular Cell, 9(3), 611–623.
65. McGuffin, L. J., Bryson, K., & Jones, D. T. (2000). The PSIPRED protein structure prediction server. Bioinformatics, 16(4), 404–405.
66. Ward, J. J., McGuffin, L. J., Bryson, K., Buxton, B. F., & Jones, D. T. (2004). The DISOPRED server for the prediction of protein disorder. Bioinformatics, 20(13), 2138–2139. doi:10.1093/bioinformatics/bth195.